160 HEALTH's stock price surged 5.36% during intraday trading on Friday, marking a significant upward movement.

The rally appears driven by the company's strategic focus on artificial intelligence in healthcare. Chairman Luo Ningzheng recently detailed the AI medical strategy, positioning the firm as a service provider for the digital transformation of public hospitals. A key development is the launch of the "160 AI Hospital" solution, which utilizes AI across the full patient journey—from pre-diagnosis triage and in-diagnosis medical record organization to post-diagnosis follow-up.

Adding to the positive sentiment is the company's financial turnaround. It reported an adjusted net profit for 2025, successfully returning to profitability. This milestone, coupled with its strategic pivot from a traffic intermediary to an AI medical infrastructure service provider, is viewed as a catalyst for the stock's recovery following a previous period of decline.